Table 1.
Participant characteristics.
| Characteristics | Total | TN types | Controls | P |
|---|---|---|---|---|
| Samples, n | 43,411 | 13,036 | 30,375 | – |
| Women, n | 18,096 | 6,625 | 11,471 | <0.001 |
| Age, years | 45.68 ± 14.08 | 52.64 ± 14.04 | 42.69 ± 13.00 | <0.001 |
| BMI, kg/m2 | 23.60 ± 3.25 | 23.85 ± 3.17 | 23.50 ± 3.27 | <0.001 |
| SP, mmHg | 126.37 ± 18.23 | 129.99 ± 19.61 | 124.81 ± 17.38 | <0.001 |
| DP, mmHg | 76.82 ± 11.95 | 77.82 ± 12.00 | 76.39 ± 11.91 | <0.001 |
| TCH, mmol/L | 4.65 ± 0.90 | 4.76 ± 0.95 | 4.60 ± 0.88 | <0.001 |
| TG, mmol/L | 1.61 ± 1.41 | 1.64 ± 1.48 | 1.59 ± 1.38 | <0.001 |
| LDL-C, mmol/L | 2.68 ± 0.79 | 2.76 ± 0.82 | 2.65 ± 0.77 | <0.001 |
| HDL-C, mmol/L | 1.38 ± 0.38 | 1.40 ± 0.39 | 1.37 ± 0.38 | <0.001 |
| 14 C-urea breath test, n (+) | 17,697 | 5,461 | 12,236 | 0.002 |
TN, thyroid nodule; BMI, body mass index; SP, systolic pressure; DP, diastolic pressure; TCH, total cholesterol; TG, triglyceride; LDL, low-density lipoprotein; HDL, high-density lipoprotein.